These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women. Yasui T, Uemura H, Tomita J, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M. Menopause; 2006; 13(4):651-9. PubMed ID: 16837887 [Abstract] [Full Text] [Related]
3. [Clinical application of undercarboxylated osteocalcin]. Yasui T, Yamada M, Irahara M. Clin Calcium; 2007 Nov; 17(11):1709-16. PubMed ID: 17982191 [Abstract] [Full Text] [Related]
6. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women. Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M. Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210 [Abstract] [Full Text] [Related]
8. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels. Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C. Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257 [Abstract] [Full Text] [Related]
10. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G. Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533 [Abstract] [Full Text] [Related]
11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M. Metabolism; 2009 Jan 11; 58(1):1-7. PubMed ID: 19059524 [Abstract] [Full Text] [Related]
12. [Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy]. Yasui T, Uemura H, Yoneda N, Irahara M, Aono T, Sunahara S, Hata K. Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jul 11; 47(7):655-61. PubMed ID: 7636337 [Abstract] [Full Text] [Related]
13. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. J Clin Invest; 1993 Apr 11; 91(4):1769-74. PubMed ID: 8473517 [Abstract] [Full Text] [Related]
14. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC. Climacteric; 2007 Oct 11; 10(5):400-7. PubMed ID: 17852143 [Abstract] [Full Text] [Related]
15. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level. Toprak A, Erenus M, Ilhan AH, Haklar G, Fak AS, Oktay A. Climacteric; 2005 Sep 11; 8(3):279-86. PubMed ID: 16390760 [Abstract] [Full Text] [Related]
16. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women. Yasui T, Miyatani Y, Tomita J, Yamada M, Uemura H, Miura M, Irahara M. Gynecol Endocrinol; 2006 Aug 11; 22(8):455-9. PubMed ID: 17012108 [Abstract] [Full Text] [Related]
17. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women. Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H. Fertil Steril; 2005 Aug 11; 84(2):384-93. PubMed ID: 16084879 [Abstract] [Full Text] [Related]